Hartford Financial Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-35
| Closed | -$10.5K | – | 407 |
|
|
2024
Q1 | $10.5K | Hold |
35
| – | – | ﹤0.01% | 308 |
|
|
2023
Q4 | $8.26K | Hold |
35
| – | – | ﹤0.01% | 318 |
|
|
2023
Q3 | $5.25K | Hold |
35
| – | – | ﹤0.01% | 331 |
|
|
2023
Q2 | $6.09K | Hold |
35
| – | – | ﹤0.01% | 309 |
|
|
2023
Q1 | $4.41K | Hold |
35
| – | – | ﹤0.01% | 316 |
|
|
2022
Q4 | $10.6K | Hold |
35
| – | – | ﹤0.01% | 277 |
|
|
2022
Q3 | $2K | Hold |
35
| – | – | ﹤0.01% | 351 |
|
|
2022
Q2 | $2K | Hold |
35
| – | – | ﹤0.01% | 357 |
|
|
2022
Q1 | $4K | Hold |
35
| – | – | ﹤0.01% | 339 |
|
|
2021
Q4 | $5K | Hold |
35
| – | – | ﹤0.01% | 321 |
|
|
2021
Q3 | $8K | Hold |
35
| – | – | ﹤0.01% | 304 |
|
|
2021
Q2 | $8K | Hold |
35
| – | – | ﹤0.01% | 308 |
|
|
2021
Q1 | $11K | Hold |
35
| – | – | ﹤0.01% | 292 |
|
|
2020
Q4 | $13K | Hold |
35
| – | – | ﹤0.01% | 268 |
|
|
2020
Q3 | $11K | Hold |
35
| – | – | ﹤0.01% | 257 |
|
|
2020
Q2 | $13K | Buy |
+35
| New | +$13K | ﹤0.01% | 250 |
|